Skip to main content
Fig. 4 | Globalization and Health

Fig. 4

From: Biopharma innovation trends during COVID-19 and beyond: an evidence from global partnerships and fundraising activities, 2011-2022

Fig. 4

The correlation between the US Fed rate and the monthly biopharma deal characteristics, 2018-2022. These panels demonstrate the relationship between the US Fed fund rate and the deal count/value and the percentage of discovery-phase deals in each year-month. We remark the months in which the count, value, or percentage is abnormally high or low

Back to article page

Globalization and Health

ISSN: 1744-8603